Trial NCT00386152

View at ClinicalTrials.gov 
Org. Study IDs: CR012985
Secondary IDs: EPOANE2007

Last trial update was posted on 2013-07-19

MeSH Interventions

Darbepoetin alfa Epoetin Alfa

MeSH Conditions

Anemia

Other Conditions

Cancer Neoplasms

Stopping Reasons

No safety signals were noted. The study was stopped because it was no longer consistent with the company's scientific and strategic focus.

Limitations And Caveats

Due to the significantly reduced power (stopped prematurely when 235 patients enrolled), all protocol-specified hypothesis tests were not performed. Instead, desriptive statistics were presented for each of the endpoints by treatment group.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID